ENTITY

Race Oncology (RAC AU)

4
Analysis
Health Care • Australia
Race Oncology Limited operates as a specialty pharmaceutical company. The Company focuses on rediscovering and bringing to market the cancer chemotherapy agent, Bisantrene.
more
bullish•Race Oncology
•11 Mar 2022 08:00•Issuer-paid

Race Oncology Ltd - Pursuing a Three-Pillar Strategy to Treat Cancer

Race Oncology Ltd Pursuing a three-pillar strategy to treat cancer Race Oncology Ltd (ASX:RAC) is a precision oncology company which listed...

Share
bullish•Race Oncology
•26 Sep 2017 21:01•Issuer-paid

Rediscovering a lost chemotherapeutic

Race Oncology is currently focused on the development of bisantrene, which had been the subject of over 40 clinical trials in the 1980s and 1990s...

Share
x